Disruption of Lrp4 function by genetic deletion or pharmacological blockade increases bone mass and serum sclerostin levels (Q34661015)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Disruption of Lrp4 function by genetic deletion or pharmacological blockade increases bone mass and serum sclerostin levels |
scientific article |
Statements
1 reference
Disruption of Lrp4 function by genetic deletion or pharmacological blockade increases bone mass and serum sclerostin levels (English)
1 reference
Ming-Kang Chang
1 reference
Ina Kramer
1 reference
Thomas Huber
1 reference
Bernd Kinzel
1 reference
Sabine Guth-Gundel
1 reference
Olivier Leupin
1 reference
Michaela Kneissel
1 reference
17 November 2014
1 reference
111
1 reference
48
1 reference
E5187-95
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference